Jefferies Group's INBX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 73,416 shares of Inhibrx Biosciences, Inc. (INBX) worth $6.96 M, representing 0.05% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in INBX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 34,443 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Inhibrx Biosciences (INBX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Inhibrx Biosciences (INBX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +34,443 | Add 88.38% | 73,416 | $94.75 |
| Q1 2026 | +30,072 | Add 337.85% | 38,973 | $67.23 |
| Q4 2025 | +8,901 | New Buy | 8,901 | $79.00 |
Jefferies Group's Inhibrx Biosciences Investment FAQs
Jefferies Group first purchased Inhibrx Biosciences, Inc. (INBX) in Q4 2025, acquiring 8,901 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Inhibrx Biosciences, Inc. (INBX) for 3 quarters since Q4 2025.
Jefferies Group's largest addition to Inhibrx Biosciences, Inc. (INBX) was in Q2 2026, adding 73,416 shares worth $6.96 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 73,416 shares of Inhibrx Biosciences, Inc. (INBX), valued at approximately $6.96 M.
As of the Q2 2026 filing, Inhibrx Biosciences, Inc. (INBX) represents approximately 0.05% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Inhibrx Biosciences, Inc. (INBX) was 73,416 shares, as reported at the end of Q2 2026.